Refractory cold agglutinin disease successfully treated with daratumumab. A case report and review of literature.

Hematology (Amsterdam, Netherlands)(2023)

引用 0|浏览0
暂无评分
摘要
Our case is the third reported case of refractory CAD successfully treated with daratumumab, which suggests that daratumumab might be a potential agent for the treatment and control of refractory Cold Agglutinin Disease.
更多
查看译文
关键词
Cold agglutinin disease, hemolytic anemia, daratumumab, autoimmune diseases, monoclonal antibodies, hemoglobin, CD 38 protein, red blood cells
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要